Search research articles
Contact Us
Filters
Showing results (671-680 of 740) with videos related to
Page
of 74
Sort By:
Cancer Discovery
|
July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
Sisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application
Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Blood Cancer Journal
|
February 2, 2022
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms
Maher Albitar, Hong Zhang, Andre Goy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 22, 2023
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis
Sebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 17, 2013
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Alexandar Tzankov, Zijun Y Xu-Monette, Marc Gerhard, et al.
The Journal of Experimental Medicine
|
November 13, 2013
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
Omar Abdel-Wahab, Jie Gao, Mazhar Adli, et al.
Blood
|
June 3, 2011
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
Santiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, et al.
The Journal of Clinical Investigation
|
January 20, 2016
Tetraspanin CD37 protects against the development of B cell lymphoma
Charlotte M de Winde, Sharon Veenbergen, Ken H Young, et al.
Haematologica
|
October 15, 2020
Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma
Youssef Youssef, Vrajesh Karkhanis, Wing Keung Chan, et al.
Science Translational Medicine
|
January 13, 2017
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Marc Damelin, Alexander Bankovich, Jeffrey Bernstein, et al.
Page
of 74
Search research articles
Search
Showing results (671-680 of 740) with videos related to
Sort By:
Page
of 74
Cancer Discovery
|
July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
Sisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application
Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Blood Cancer Journal
|
February 2, 2022
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms
Maher Albitar, Hong Zhang, Andre Goy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 22, 2023
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis
Sebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 17, 2013
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Alexandar Tzankov, Zijun Y Xu-Monette, Marc Gerhard, et al.
The Journal of Experimental Medicine
|
November 13, 2013
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
Omar Abdel-Wahab, Jie Gao, Mazhar Adli, et al.
Blood
|
June 3, 2011
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
Santiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, et al.
The Journal of Clinical Investigation
|
January 20, 2016
Tetraspanin CD37 protects against the development of B cell lymphoma
Charlotte M de Winde, Sharon Veenbergen, Ken H Young, et al.
Haematologica
|
October 15, 2020
Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma
Youssef Youssef, Vrajesh Karkhanis, Wing Keung Chan, et al.
Science Translational Medicine
|
January 13, 2017
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Marc Damelin, Alexander Bankovich, Jeffrey Bernstein, et al.
Page
of 74